Related Experiment Video
Updated: Dec 23, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Cardiovascular disease in HIV patients: recent advances in predicting and managing risk
Padraig McGettrick1, Patrick W G Mallon1,2, Caroline A Sabin3
1Centre for Pathogen Host Research, UCD School of Medicine, University College Dublin , Dublin, Ireland.
Insights
Cardiovascular disease (CVD) is a major concern for people with HIV (PLWH). Understanding and managing CVD risk factors, both general and HIV-specific, is crucial for improving health outcomes in this growing population.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in people living with HIV (PLWH).
- An aging PLWH population presents unique challenges for CVD risk management.
- CVD risk factors in PLWH may differ from the general population.
Purpose of the Study:
- To review current data on CVD prevalence, pathogenesis, and contributing factors in PLWH.
- To examine CVD risk prediction models and influencing factors (general and HIV-specific) in PLWH.
- To discuss CVD risk management strategies and future therapeutic avenues for PLWH.
Main Methods:
- Comprehensive literature review of CVD in HIV infection.
- Analysis of data on CVD prevalence, pathogenesis, and risk factors.
- Synthesis of information on risk prediction, management, and future therapies.
Main Results:
- CVD is a significant health challenge for aging PLWH.
- Multiple, potentially distinct, factors contribute to CVD risk in PLWH.
- Effective risk prediction and management strategies are essential.
Conclusions:
- Addressing CVD risk in PLWH requires a multifaceted approach.
- Further research into HIV-specific CVD pathways is needed.
- Future management strategies should focus on personalized and preventative care.
Introduction:
Cardiovascular disease (CVD) is one of the leading causes of mortality in virally suppressed people living with HIV (PLWH) and with an aging population, is likely to become one of the leading challenges in maintaining good health outcomes in HIV infection. However, factors driving the risk of CVD in PLWH are multiple and may be different from those of the general population, raising challenges to predicting and managing CVD risk in this population.
Areas Covered:
In this review, we examine the relevant data regarding CVD in HIV infection including CVD prevalence, pathogenesis, and other contributing factors. We review the data regarding CVD risk prediction in PLWH and summarize factors, both general and HIV specific, that may influence CVD risk in this population. And finally, we discuss appropriate management of CVD risk in PLWH and explore potential therapeutic pathways which may mitigate CVD risk in the future in this population.
Expert Opinion:
Following a comprehensive review of CVD risk in PLWH, we give our opinion on the primary issues in risk prediction and management of CVD in HIV infected individuals and discuss the future direction of CVD management in this population.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Retrovirus Life Cycles
Rheumatic Heart Disease III: Medical Management
Sexually Transmitted Infections

